Factors Influencing the Severity of Pneumonitis Associated with Immune Checkpoint Inhibitors: Insights from Clinical, Radiological, and Laboratory Data in Real-World Settings - Top-Institutions - MDSpire

Factors Influencing the Severity of Pneumonitis Associated with Immune Checkpoint Inhibitors: Insights from Clinical, Radiological, and Laboratory Data in Real-World Settings

  • By

  • Esma Sevil Akkurt

  • Ozlem Duvenci Birben

  • Ilknur Deliktas Onur

  • Duygu Dagli

  • Ozturk Ates

  • Derya Yenibertiz

  • January 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Pulmonology
    • Immunotherapy Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Pulmonary Medicine
    • Immunotherapy

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Pulmonology
    • Immunotherapy Toxicity Management

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Pulmonology
    • Immunology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Pulmonology
    • Immunotherapy Research

Original Source(s)

Factors Influencing the Severity of Pneumonitis Associated with Immune Checkpoint Inhibitors: Insights from Clinical, Radiological, and Laboratory Data in Real-World Settings

  • by Esma Sevil Akkurt, Ozlem Duvenci Birben, Ilknur Deliktas Onur, Duygu Dagli, Ozturk Ates, Derya Yenibertiz

  • January 28, 2026

Related Content

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment